Stock Overview
Elanco Animal Health (ELAN)
NYSE · Healthcare · Drug Manufacturers - Specialty & Generic
Elanco Animal Health is a Healthcare company with a market capitalization of $12.27B.
Market Cap
$12.27B
Forward P/E
19.3
Price/Sales
2.5
Price/Book
1.9
EV/EBITDA
21.7
Beta
1.70
EPS (TTM)
$-0.50
Profit Margin
-5.0%
ROE
-3.8%
52W High
$27.72
52W Low
$13.39
5-Year Price History
Latest Annual Financials · FY ending December 31, 2025
Revenue
$4.71B
Gross Profit
$2.05B
Operating Income
$252.00M
Net Income
-$232.00M
Free Cash Flow
$284.00M
Total Debt
$4.02B
Cash & Equivalents
$545.00M
Shareholder Equity
$6.55B
Recent Quarterly Earnings (EPS)
| Quarter | Reported | Actual EPS | Estimate | Surprise |
|---|---|---|---|---|
| Q1 2026 | May 6, 2026 | $0.40 | $0.34 | +17.6% |
| Q4 2025 | February 24, 2026 | $0.13 | $0.11 | +14.5% |
| Q3 2025 | November 5, 2025 | $0.19 | $0.13 | +46.2% |
| Q2 2025 | August 7, 2025 | $0.26 | $0.20 | +30.0% |
| Q1 2025 | May 7, 2025 | $0.37 | $0.30 | +23.3% |
| Q4 2024 | February 25, 2025 | $0.14 | $0.15 | -5.8% |
Other Drug Manufacturers - Specialty & Generic Stocks
Frequently Asked Questions
What is Elanco Animal Health's market cap?
As of June 29, 2026, Elanco Animal Health (ELAN) has a market capitalization of $12.27B.
Does Elanco Animal Health pay a dividend?
Elanco Animal Health does not currently pay a dividend.
What sector is ELAN in?
Elanco Animal Health is in the Healthcare sector, specifically the Drug Manufacturers - Specialty & Generic industry.
What was Elanco Animal Health's revenue?
In its latest reported fiscal year (ending December 31, 2025), Elanco Animal Health reported revenue of $4.71B and net income of -$232.00M.
Ask your own questions about ELAN
Try mrmarket.ai freeData as of June 29, 2026. Figures are sourced from company filings and market data and may be delayed or revised. For informational purposes only — not investment advice.